IT-DIAB Trademark

Trademark Overview


On Monday, January 30, 2017, a trademark application was filed for IT-DIAB with the United States Patent and Trademark Office. The USPTO has given the IT-DIAB trademark a serial number of 87317376. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Monday, September 9, 2024. This trademark is owned by GENFIT. The IT-DIAB trademark is filed in the Chemical Products, Pharmaceutical Products, Computer & Software Products & Electrical & Scientific Products, and Computer & Software Services & Scientific Services categories with the following description:

Electronic databases and computer programs for retrieving, compiling, integrating and sending data relating to research on type II diabetes, prediabetes and their associated acute or chronic complications in particular experimental data concerning the targets, biomarkers, cellular models and animal testing models which are being used or developed; Electronic databases and computer programs for retrieving, compiling, integrating and sending data relating to methods for the preventive or curative treatment of type II diabetes, of prediabetes and their acute or chronic complications; Electronic databases and computer programs for retrieving, compiling, integrating and sending medical data relating to the condition of patients monitored for the preventive or curative treatment of type II diabetes, of prediabetes and their acute or chronic complications

Pharmaceutical preparations and substances, preparations for medical use, for the preventive and curative treatment of type II diabetes, of prediabetes and their acute or chronic complications; Preparations, products and devices for medical use, in particular, diagnostic biomarkers and cellular models for the in vivo, ex vivo or in vitro diagnosis of type II diabetes, of prediabetes and their associated acute or chronic complications; Preparations, products and devices, in particular, diagnostic biomarkers and cellular models for the medical follow-up of patients at risk or of patients suffering from type II diabetes, prediabetes and their associated acute or chronic complications; Preparations, products and devices in particular diagnostic biomarkers and cellular models for the selection and assessment of drugs and their compounds for their preventive and curative properties towards type II diabetes, prediabetes and their associated acute or chronic complications

Active principles, namely, active chemical ingredients used in manufacturing pharmaceuticals for treating type II diabetes, prediabetes and their acute or chronic complications

Scientific research in the field of prevention, diagnosis, screening, preventive or curative treatment of type II diabetes, of prediabetes and their acute or chronic complications; Scientific research, in particular clinical research on the assessment of the effects of drugs and their compounds having preventive or curative properties of type II diabetes, prediabetes and their acute or chronic complications; Development and validation of tests for the diagnosis and medical follow-up of patients at risk or of patients suffering from type II diabetes, prediabetes and their associated acute or chronic complications; Development and validation of biological tests in vitro, ex vivo and in vivo for sorting and selecting compounds, products and substances intended for the preventive or curative treatment of type II diabetes, prediabetes and their associated acute or chronic complications
it-diab

General Information


Serial Number87317376
Word MarkIT-DIAB
Filing DateMonday, January 30, 2017
Status710 - CANCELLED - SECTION 8
Status DateMonday, September 9, 2024
Registration Number5410374
Registration DateTuesday, February 27, 2018
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 12, 2017

Trademark Statements


Goods and ServicesElectronic databases and computer programs for retrieving, compiling, integrating and sending data relating to research on type II diabetes, prediabetes and their associated acute or chronic complications in particular experimental data concerning the targets, biomarkers, cellular models and animal testing models which are being used or developed; Electronic databases and computer programs for retrieving, compiling, integrating and sending data relating to methods for the preventive or curative treatment of type II diabetes, of prediabetes and their acute or chronic complications; Electronic databases and computer programs for retrieving, compiling, integrating and sending medical data relating to the condition of patients monitored for the preventive or curative treatment of type II diabetes, of prediabetes and their acute or chronic complications
Goods and ServicesPharmaceutical preparations and substances, preparations for medical use, for the preventive and curative treatment of type II diabetes, of prediabetes and their acute or chronic complications; Preparations, products and devices for medical use, in particular, diagnostic biomarkers and cellular models for the in vivo, ex vivo or in vitro diagnosis of type II diabetes, of prediabetes and their associated acute or chronic complications; Preparations, products and devices, in particular, diagnostic biomarkers and cellular models for the medical follow-up of patients at risk or of patients suffering from type II diabetes, prediabetes and their associated acute or chronic complications; Preparations, products and devices in particular diagnostic biomarkers and cellular models for the selection and assessment of drugs and their compounds for their preventive and curative properties towards type II diabetes, prediabetes and their associated acute or chronic complications
Goods and ServicesActive principles, namely, active chemical ingredients used in manufacturing pharmaceuticals for treating type II diabetes, prediabetes and their acute or chronic complications
Goods and ServicesScientific research in the field of prevention, diagnosis, screening, preventive or curative treatment of type II diabetes, of prediabetes and their acute or chronic complications; Scientific research, in particular clinical research on the assessment of the effects of drugs and their compounds having preventive or curative properties of type II diabetes, prediabetes and their acute or chronic complications; Development and validation of tests for the diagnosis and medical follow-up of patients at risk or of patients suffering from type II diabetes, prediabetes and their associated acute or chronic complications; Development and validation of biological tests in vitro, ex vivo and in vivo for sorting and selecting compounds, products and substances intended for the preventive or curative treatment of type II diabetes, prediabetes and their associated acute or chronic complications

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateMonday, September 9, 2024
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateMonday, September 9, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus.
US Class Codes021, 023, 026, 036, 038
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateMonday, September 9, 2024
Primary Code009
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateMonday, September 9, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGENFIT
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressLoos 59120
FR

Party NameGENFIT
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressLoos 59120
FR

Party NameGENFIT
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressLoos 59120
FR

Trademark Events


Event DateEvent Description
Tuesday, April 25, 2017NON-FINAL ACTION WRITTEN
Thursday, February 2, 2017NEW APPLICATION ENTERED
Thursday, February 2, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, April 25, 2017ASSIGNED TO EXAMINER
Tuesday, April 25, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, April 25, 2017NON-FINAL ACTION E-MAILED
Friday, October 20, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, October 20, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, October 21, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, December 12, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 27, 2018REGISTERED-PRINCIPAL REGISTER
Monday, September 9, 2024CANCELLED SEC. 8 (6-YR)
Monday, February 27, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, October 31, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 22, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 12, 2017PUBLISHED FOR OPPOSITION